Neurotoxin therapy for inner ear disorders
US6358926B2 · kind B2 · utility
88Cited by
3References
19Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 24, 2001 |
| Grant date | Mar 19, 2002 |
| Priority date | — |
| Expiry date | May 24, 2021 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods for treating otic disorders by local administration of a neurotoxin. A botulinum toxin can be administered to myoclonic middle ear muscles and to inner ear efferent and/or afferent nerves to alleviate otic disorders such as tinnitus, cochlear nerve dysfunction and Meniere's disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.